Athensmed
VC Fund
Athensmed is a VC fund focused on Health Care and Health Diagnostics. Athensmed Oy
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Athensmed invests in
Stages Athensmed invests in
Countries Athensmed invests in
Round sizes
Round size
- Seed
- $1.1M–$4.3M
Investment Focus
Industry
- Health Care 3 (60%)
- Health Diagnostics 3 (60%)
- Medical 2 (40%)
- Software 2 (40%)
- Medical Device 2 (40%)
Stage
- Seed 3 (60%)
- Series A 1 (20%)
- Funding Round 1 (20%)
Country
- Finland 4 (80%)
- Switzerland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Moncyte Health
|
Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease. | $1.1M / Seed / Oct 08, 2024 | |
Finnadvance
|
Finnadvance specializes in tailored hardware solutions and bio-materials for cell culture, and microfluidic design and fabrication, and our robotics sector provides aerial imaging and analysis services for forest, agriculture and other assets and stockpile management. | $1.3M / Seed / Apr 08, 2022 | |
Biospectal
|
Biospectal is the remote patient monitoring and biosensing software company, developed the OptiBP smartphone app and data platform to empower people worldwide with a medical-grade device integrated directly into their smartphone for instantaneous blood pressure measurement and monitoring, anytime and anywhere. The app runs on a typical smartphoneand uses the built-in camera to record and measure a user’s blood flow via their fingertip quickly and easily. A measurement is rendered in approximately 20 seconds — half the time of a typical blood pressure cuff. The company’s proprietary algorithms and optical signal capture methods then transform the captured data into blood pressure values. The Biospectal OptiBP for Android public beta is available now in the US, UK, France, Germany, Spain and Switzerland. | $4.3M / Seed / Jul 01, 2021 | |
VideoVisit
|
VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone. | $1.7M / May 13, 2019 | |
Kaiku Health
|
Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation. | $4.8M / Series A / Apr 05, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Athensmed invest in?
Athensmed invests primarily in Health Care, Health Diagnostics and Medical startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Athensmed's check size?
Athensmed typically joins rounds of $1.1M–$4.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Athensmed participates in.
When did Athensmed last invest?
The most recent investment recorded for Athensmed closed in Oct 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
